Articles dans des revues avec comité de lecture (26)
  1. 1. Otmani, K., Rouas, R., Berehab, M., & Lewalle, P. (2024). The regulatory mechanisms of oncomiRs in cancer. Biomedicine & pharmacotherapy, 171, 116165. doi:10.1016/j.biopha.2024.116165
  2. 2. Otmani, K., Rouas, R., Lagneaux, L., Krayem, M., Duvillier, H., Berehab, M., & Lewalle, P. (2023). Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways. Cell Communication and Signaling, 21(1), 253. doi:10.1186/s12964-023-01259-1
  3. 3. Otmani, K., Rouas, R., & Lewalle, P. (2022). OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications. Frontiers in immunology, 13, 913951. doi:10.3389/fimmu.2022.913951
  4. 4. Berehab, M., Rouas, R., Akl, H., Duvillier, H., Journé, F., Fayyad Kazan, H., Ghanem, G. E., Bron, D., Lewalle, P., & Merimi, M. (2021). Apoptotic and non-apoptotic modalities of thymoquinone-induced lymphoma cell death: Highlight of the role of cytosolic calcium and necroptosis. Cancers (Basel), 13(14), 3579. doi:10.3390/cancers13143579
  5. 5. Cogels, M., Rouas, R., Ghanem, G. E., Martinive, P., Awada, A., Van Gestel, D., & Krayem, M. (2021). Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research. Frontiers in oncology, 11, 784947. doi:10.3389/fonc.2021.784947
  6. 6. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Fayyad Kazan, H., Lagneaux, L., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction. Cells, 9(9). doi:10.3390/cells9092053
  7. 7. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Naamane, N., Fayyad Kazan, H., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs. International journal of molecular sciences, 21(19). doi:10.3390/ijms21197065
  8. 8. Rouas, R., Merimi, M., Najar, M., Zein, N. E., Fayyad Kazan, M., Berehab, M., Moussa Agha, D., Bron, D., Burny, A., Rachidi, W., Badran, B., Lewalle, P., & Fayyad Kazan, H. (2019). Human CD8+ CD25 + CD127 low regulatory T cells: microRNA signature and impact on TGF-β and IL-10 expression. Journal of cellular physiology, 234(10), 17459-17472. doi:10.1002/jcp.28367
  9. 9. Al-Akoum, C., Badran, B., Akl, I., Rouas, R., Fayyad Kazan, M., Falha, L., Renno, T., Burny, A., Lewalle, P., & Fayyad Kazan, H. (2015). NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cells. Human immunology, 76(5), 307-317. doi:10.1016/j.humimm.2015.03.010
  10. 10. Jebbawi, F., Fayyad Kazan, H., Merimi, M., Lewalle, P., Verougstraete, J. C., Leo, O., Romero, P., Burny, A., Badran, B., Martiat, P., & Rouas, R. (2014). A microRNA profile of human CD8+ regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes. Journal of translational medicine, 12(1), 218. doi:10.1186/s12967-014-0218-x
  11. 11. Fayyad Kazan, H., Rouas, R., Burny, A., Martiat, P., Hamade, E., El Zein, N., ElDirani, R., Hussein, N., Fakhry, M., Al-Akoum, C., Badran, B., Najar, M., & Fayyad Kazan, M. (2014). Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-γ secreted by activated human CD4 lymphocytes. Human immunology, 75(7), 677-685. doi:10.1016/j.humimm.2014.01.007
  12. 12. Fayyad Kazan, H., Bitar, N., Najar, M., Lewalle, P., Fayyad Kazan, M., Badran, R., Hamade, E., Daher, A., Hussein, N., ElDirani, R., Berri, F., Vanhamme, L., Burny, A., Martiat, P., Rouas, R., & Badran, B. (2013). Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Journal of translational medicine, 11, 31. doi:10.1186/1479-5876-11-31
    13. << Précédent 1 2 3 Suivant >>